milrinone has been researched along with sildenafil citrate in 30 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 14 (46.67) | 29.6817 |
| 2010's | 12 (40.00) | 24.3611 |
| 2020's | 4 (13.33) | 2.80 |
| Authors | Studies |
|---|---|
| Adachi, H; Ishibashi, K; Ishihara, H; Kabasawa, Y; Kakiki, M; Kodama, K; Matsukura, M; Miyazaki, K; Nishino, M; Ozaki, H; Takase, Y; Watanabe, N | 1 |
| Becker, AJ; Forssmann, WG; Harringer, W; Jonas, U; Stief, CG; Truss, MC; Uckert, S | 1 |
| Clancy, J; Kraft, P; Lombardi, E; Qiu, Y | 1 |
| Bischoff, E; Schneider, K | 1 |
| Bertel, O; Brunner-La Rocca, HP; Kiowski, W; Oechslin, E; Schad, K; Schalcher, C; Scharf, C; Schindler, R; Suetsch, G | 1 |
| Clancy, JP; Cobb, BR; Fan, L; Kovacs, TE; Sorscher, EJ | 1 |
| Böhm, M; Cremers, B; Maack, C; Schäfers, HJ; Scheler, M; Südkamp, M; Wendler, O | 1 |
| Ravishankar, C; Tabbutt, S; Wernovsky, G | 1 |
| Beaver, TM; Hess, PJ; Klodell, CT; Lobato, EB; Martin, TD; Staples, ED; Trachte, AL; Urdaneta, F | 1 |
| Abdollahi, M; Khorasani, R; Milani, E; Nikfar, S; Zamani, MJ | 1 |
| Beaver, T; Kirby, DS; Klodell, C; Lobato, EB; Muehlschlegel, J; Sidi, A | 1 |
| Beaver, T; Kirby, DS; Klodell, C; Lobato, EB; Muehlschlegel, JD; Sidi, A; Urdaneta, F | 1 |
| Bossone, E; De Felice, C; Del Vecchio, A; Latini, G; Verrotti, A | 1 |
| Botha, P; Dark, JH; Macgowan, GA; Parry, G | 1 |
| Obmińska-Mrukowicz, B; Szczypka, M | 1 |
| Birowo, P; Kedia, GT; Kuczyk, MA; Rahardjo, D; Sandner, P; Scheller, F; Sonnenberg, JE; Thon, WF; Uckert, S | 1 |
| Steinhorn, RH | 2 |
| de A Cavalcante, F; de Correia, AC; de Lira, DP; de O Santos, BV; Macêdo, CL; Martins, IR; Silva, BA; Vasconcelos, LH | 1 |
| Radulova, P; Slancheva, B; Vakrilova, L | 1 |
| Flett, J; Griselli, M; Hasan, A; Hewitt, T; Kirk, R; Peng, E; Schueler, S; Woods, A; Wrightson, N | 1 |
| Airan, B; Gulati, GS; Gupta, SK; Rajashekar, P; Talwar, S | 1 |
| Luecke, C; McPherson, C | 1 |
| Al-Shehri, S; El Askary, A; El-Esawy, B; Mehanna, OM | 1 |
| Bajnok, A; Orbán, C; Sava, F; Toldi, G; Vásárhelyi, Z | 1 |
| Hötzel, A; Loop, T | 1 |
| Antonios, MAM; El-Ghandour, M; Ghanem, M; Hammad, B | 1 |
| Abman, SH; Kinsella, JP; Mandell, E | 1 |
| Feige, K; Heinen, A; Hollmann, MW; Huhn, R; Maas, K; Raupach, A; Stroethoff, M; Torregroza, C | 1 |
| El-Farrash, RA; Imam, SS; Saleh, GA; Taha, AS | 1 |
8 review(s) available for milrinone and sildenafil citrate
| Article | Year |
|---|---|
Critical care in cardiovascular medicine.
Topics: Cardiac Output, Low; Cardiac Surgical Procedures; Cardiotonic Agents; Child; Critical Care; Dye Dilution Technique; Heart-Assist Devices; Humans; Hypertension, Pulmonary; Iloprost; Intraoperative Care; Milrinone; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Vasodilator Agents | 2003 |
Oral sildenafil reduces pulmonary hypertension after cardiac surgery.
Topics: Adult; Aged; Cardiac Surgical Procedures; Drug Evaluation; Drug Resistance; Female; Hemodynamics; Humans; Hypertension, Pulmonary; Male; Middle Aged; Milrinone; Nitric Oxide; Nitroglycerin; Nitroprusside; Phosphodiesterase Inhibitors; Piperazines; Postoperative Complications; Purines; Retrospective Studies; Sildenafil Citrate; Sulfones; Vascular Resistance; Vasodilator Agents | 2005 |
Persistent pulmonary hypertension of the newborn: therapeutical approach.
Topics: Administration, Inhalation; Humans; Infant, Newborn; Milrinone; Nitric Oxide; Persistent Fetal Circulation Syndrome; Piperazines; Purines; Sildenafil Citrate; Sulfones | 2008 |
[BRONCHOPULMONARY DYSPLASIA--WHAT DO WE KNOW TODAY?].
Topics: Antihypertensive Agents; Birth Weight; Bronchodilator Agents; Bronchopulmonary Dysplasia; Epoprostenol; Female; Gestational Age; Humans; Infant, Newborn; Lung; Milrinone; Nitric Oxide; Pregnancy; Sildenafil Citrate; Vasodilator Agents | 2015 |
Advances in Neonatal Pulmonary Hypertension.
Topics: Administration, Inhalation; Disease Management; Extracorporeal Membrane Oxygenation; Humans; Hydrocortisone; Infant, Newborn; Milrinone; Nitric Oxide; Oxygen Inhalation Therapy; Persistent Fetal Circulation Syndrome; Pulmonary Surfactants; Randomized Controlled Trials as Topic; Sildenafil Citrate; Treatment Outcome; Vasodilator Agents | 2016 |
Treatment of Persistent Pulmonary Hypertension of the Newborn: Use of Pulmonary Vasodilators in Term Neonates.
Topics: Bosentan; Humans; Infant, Newborn; Milrinone; Nitric Oxide; Oxygen Inhalation Therapy; Persistent Fetal Circulation Syndrome; Prostaglandins; Sildenafil Citrate; Sulfonamides; Treatment Outcome; Vasodilator Agents | 2017 |
[Anaesthesia in Patients with Pulmonary Hypertension].
Topics: Anesthesia, General; Anesthetics; Humans; Hypertension, Pulmonary; Milrinone; Nitric Oxide; Sildenafil Citrate; Vasodilator Agents | 2019 |
Persistent pulmonary hypertension of the newborn.
Topics: Bosentan; Epoprostenol; Humans; Hypertension, Pulmonary; Hypoxia; Infant; Infant, Newborn; Infant, Premature; Lung; Milrinone; Nitric Oxide; Oxygen; Persistent Fetal Circulation Syndrome; Pulmonary Alveoli; Pulmonary Surfactants; Risk; Sildenafil Citrate; Vascular Resistance; Vasodilator Agents | 2021 |
4 trial(s) available for milrinone and sildenafil citrate
| Article | Year |
|---|---|
Interaction of sildenafil with cAMP-mediated vasodilation in vivo.
Topics: Adrenergic beta-Agonists; Adult; Blood Pressure; Brachial Artery; Cyclic AMP; Cyclic GMP; Forearm; Heart Rate; Hemodynamics; Humans; Isoproterenol; Male; Milrinone; Nitroglycerin; Phosphodiesterase Inhibitors; Piperazines; Purines; Regional Blood Flow; Sildenafil Citrate; Sulfones; Vasodilation; Vasodilator Agents | 2002 |
Acute hemodynamic effects of intravenous sildenafil citrate in congestive heart failure: comparison of phosphodiesterase type-3 and -5 inhibition.
Topics: Adult; Blood Pressure; Cyclic Nucleotide Phosphodiesterases, Type 3; Cyclic Nucleotide Phosphodiesterases, Type 5; Female; Heart Failure; Heart Rate; Heart Transplantation; Humans; Hypertension, Pulmonary; Injections, Intravenous; Male; Middle Aged; Milrinone; Phosphodiesterase 3 Inhibitors; Phosphodiesterase 5 Inhibitors; Phosphodiesterase Inhibitors; Piperazines; Pulmonary Wedge Pressure; Purines; Sildenafil Citrate; Sulfones; Vascular Resistance | 2009 |
Efficacy of Milrinone Plus Sildenafil in the Treatment of Neonates with Persistent Pulmonary Hypertension in Resource-Limited Settings: Results of a Randomized, Double-Blind Trial.
Topics: Double-Blind Method; Female; Humans; Hypertension, Pulmonary; Infant, Newborn; Male; Milrinone; Sildenafil Citrate; Vasodilator Agents | 2020 |
Milrinone Versus Sildenafil in Treatment of Neonatal Persistent Pulmonary Hypertension: A Randomized Control Trial.
Topics: Humans; Hypertension, Pulmonary; Infant, Newborn; Milrinone; Nitric Oxide; Persistent Fetal Circulation Syndrome; Sildenafil Citrate; Vasodilator Agents | 2022 |
18 other study(ies) available for milrinone and sildenafil citrate
| Article | Year |
|---|---|
4-(3-Chloro-4-methoxybenzyl)aminophthalazines: synthesis and inhibitory activity toward phosphodiesterase 5.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Antihypertensive Agents; Biological Availability; Blood Pressure; Coronary Vessels; Cyclic Nucleotide Phosphodiesterases, Type 5; Dinoprost; Hypertension, Pulmonary; In Vitro Techniques; Male; Muscle Relaxation; Muscle, Smooth, Vascular; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Phthalazines; Piperidines; Quinazolines; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Swine; Vasodilator Agents | 2000 |
Effects of sildenafil on cAMP and cGMP levels in isolated human cavernous and cardiac tissue.
Topics: Colforsin; Cyclic AMP; Cyclic GMP; Heart; Humans; In Vitro Techniques; Male; Milrinone; Myocardium; Penis; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones | 2000 |
Rabbit corpus cavernosum smooth muscle shows a different phosphodiesterase profile than human corpus cavernosum.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Cyclic AMP; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 1; Cyclic Nucleotide Phosphodiesterases, Type 3; Cyclic Nucleotide Phosphodiesterases, Type 5; Disease Models, Animal; Exonucleases; Humans; Isoenzymes; Male; Milrinone; Muscle Tonus; Muscle, Smooth; Penis; Phosphodiesterase I; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Piperazines; Purines; Rabbits; Second Messenger Systems; Sildenafil Citrate; Species Specificity; Sulfones | 2000 |
A conscious-rabbit model to study vardenafil hydrochloride and other agents that influence penile erection.
Topics: Adrenergic alpha-Antagonists; Animals; Chinchilla; Drug Synergism; Imidazoles; Male; Milrinone; NG-Nitroarginine Methyl Ester; Nitric Oxide Donors; Nitroprusside; Penile Erection; Phentolamine; Phosphodiesterase Inhibitors; Piperazines; Purines; Rabbits; Sildenafil Citrate; Sulfones; Triazines; Vardenafil Dihydrochloride | 2001 |
Adenosine receptors and phosphodiesterase inhibitors stimulate Cl- secretion in Calu-3 cells.
Topics: Adenosine Deaminase; Anions; Cell Line; Chlorine; Cilostazol; Colforsin; Cyclic AMP; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Electrophysiology; Epithelium; Glyburide; Humans; Hypoglycemic Agents; Milrinone; Mutation; Papaverine; Phosphodiesterase Inhibitors; Piperazines; Purines; Receptors, Purinergic P1; Rolipram; Sildenafil Citrate; Sulfones; Tetrazoles; Time Factors | 2003 |
Effects of sildenafil (viagra) on human myocardial contractility, in vitro arrhythmias, and tension of internal mammaria arteries and saphenous veins.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Arrhythmias, Cardiac; Cyclic Nucleotide Phosphodiesterases, Type 5; Electric Stimulation; Heart Atria; Heart Ventricles; Humans; In Vitro Techniques; Isometric Contraction; Isoproterenol; Mammary Arteries; Milrinone; Muscle, Smooth, Vascular; Myocardial Contraction; Nitric Oxide Donors; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Piperazines; Purines; S-Nitroso-N-Acetylpenicillamine; Saphenous Vein; Sildenafil Citrate; Sulfones; Vasodilation; Vasodilator Agents | 2003 |
Reduction of diabetes-induced oxidative stress by phosphodiesterase inhibitors in rats.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Lipid Peroxidation; Male; Milrinone; Oxidative Stress; Phosphodiesterase Inhibitors; Piperazines; Purines; Rats; Rats, Wistar; Sildenafil Citrate; Sulfones; Theophylline; Thiobarbituric Acid Reactive Substances | 2005 |
Treatment with phosphodiesterase inhibitors type III and V: milrinone and sildenafil is an effective combination during thromboxane-induced acute pulmonary hypertension.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 3',5'-Cyclic-AMP Phosphodiesterases; Acute Disease; Animals; Cyclic Nucleotide Phosphodiesterases, Type 3; Cyclic Nucleotide Phosphodiesterases, Type 4; Disease Models, Animal; Drug Evaluation; Drug Therapy, Combination; Hemodynamics; Hypertension, Pulmonary; Milrinone; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Swine; Vascular Resistance; Vasoconstrictor Agents; Vasodilator Agents | 2006 |
Treating pulmonary hypertension post cardiopulmonary bypass in pigs: milrinone vs. sildenafil analog.
Topics: Acute Disease; Animals; Blood Pressure; Cardiopulmonary Bypass; Hypertension, Pulmonary; Milrinone; Phosphodiesterase 5 Inhibitors; Phosphodiesterase Inhibitors; Piperazines; Purines; Pyrimidinones; Reperfusion Injury; Sildenafil Citrate; Sulfones; Sus scrofa; Vascular Resistance | 2008 |
The effects of selective and nonselective phosphodiesterase inhibitors on phagocytic cells in mice.
Topics: Aminophylline; Animals; Female; Interleukin-1beta; Macrophages, Peritoneal; Mice; Mice, Inbred BALB C; Milrinone; Monocytes; Nitric Oxide; Phagocytes; Phosphodiesterase Inhibitors; Piperazines; Purines; Respiratory Burst; Sildenafil Citrate; Sulfones | 2010 |
Exposure of human seminal vesicle tissue to phosphodiesterase (PDE) inhibitors antagonizes the contraction induced by norepinephrine and increases production of cyclic nucleotides.
Topics: 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Aged; Colforsin; Cyclic AMP; Cyclic GMP; Drug Evaluation, Preclinical; Ejaculation; Humans; In Vitro Techniques; Male; Milrinone; Muscle Relaxation; Nitroprusside; Norepinephrine; Phosphodiesterase Inhibitors; Piperazines; Purines; Receptors, Adrenergic, alpha; Rolipram; Seminal Vesicles; Sildenafil Citrate; Sulfones | 2010 |
Diagnosis and treatment of pulmonary hypertension in infancy.
Topics: Bosentan; Bronchopulmonary Dysplasia; Hernia, Diaphragmatic; Humans; Hypertension, Pulmonary; Infant, Newborn; Milrinone; Nitric Oxide; Piperazines; Prostaglandins; Purines; Signal Transduction; Sildenafil Citrate; Sulfonamides; Sulfones; Vascular Resistance | 2013 |
Mechanisms underlying vasorelaxation induced in rat aorta by galetin 3,6-dimethyl ether, a flavonoid from Piptadenia stipulacea (Benth.) Ducke.
Topics: Aminophylline; Animals; Aorta; Calcium Chloride; Fabaceae; Flavonoids; In Vitro Techniques; Male; Milrinone; Myocardial Contraction; Phenylephrine; Piperazines; Potassium Channel Blockers; Purines; Rats, Wistar; Sildenafil Citrate; Sulfonamides; Vasodilation; Verapamil | 2014 |
Successful HeartWare Bridge to Recovery in a 3-Year Old: A Game Changer?
Topics: Anticoagulants; Biopsy; Cardiomyopathy, Dilated; Child, Preschool; Combined Modality Therapy; Heart Failure; Heart-Assist Devices; Humans; Imaging, Three-Dimensional; Male; Milrinone; Myocarditis; Myocardium; Recovery of Function; Sildenafil Citrate; Thrombosis; Tomography, X-Ray Computed; Vasodilator Agents | 2016 |
Crossed Pulmonary Arteries in a Patient With Persistent Truncus Arteriosus.
Topics: Abnormalities, Multiple; Anastomosis, Surgical; Cardiomegaly; Cardiopulmonary Bypass; Combined Modality Therapy; Dobutamine; Female; Humans; Hypertension, Pulmonary; Infant; Milrinone; Pulmonary Artery; Sildenafil Citrate; Truncus Arteriosus, Persistent; Vascular Surgical Procedures | 2016 |
Effect of phosphodiesterase inhibitors on renal functions and oxidant/antioxidant parameters in streptozocin-induced diabetic rats.
Topics: Animals; Antioxidants; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Hyperglycemia; Hypoglycemic Agents; Insulin Resistance; Kidney; Lipid Peroxidation; Male; Milrinone; Oxidative Stress; Oxidoreductases; Pentoxifylline; Phosphodiesterase 3 Inhibitors; Phosphodiesterase 5 Inhibitors; Phosphodiesterase Inhibitors; Random Allocation; Rats, Sprague-Dawley; Renal Insufficiency; Sildenafil Citrate | 2018 |
Effects of caffeine and phosphodiesterase inhibitors on activation of neonatal T lymphocytes.
Topics: Adenosine A2 Receptor Antagonists; Adult; Aging; Caffeine; Calcium Signaling; Cells, Cultured; Cyclic AMP; Cytokines; Female; Humans; Infant, Newborn; Leukocytes, Mononuclear; Lymphocyte Activation; Male; Milrinone; Phosphodiesterase Inhibitors; Reactive Oxygen Species; Sildenafil Citrate; T-Lymphocytes; Triazines; Triazoles | 2018 |
Combination of the Phosphodiesterase Inhibitors Sildenafil and Milrinone Induces Cardioprotection With Various Conditioning Strategies.
Topics: Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Hemodynamics; Isolated Heart Preparation; Male; Milrinone; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Phosphodiesterase 3 Inhibitors; Phosphodiesterase 5 Inhibitors; Rats, Wistar; Sildenafil Citrate; Ventricular Function, Left | 2020 |